Table 5.
Variable | No. (%) of patients* | p value | |
---|---|---|---|
No WSC n = 104 |
WSC n = 48 |
||
Planned initial management | |||
Nonoperative | 83 (79.8) | 48 (100.0) | < 0.001§¶ |
Operative | 21 (20.2) | 0 (0.0) | |
Nasogastric tube use | 81 (77.9) | 48 (100.0) | < 0.001§¶ |
Failed nonoperative intent, required surgery | 3 (3.6) | 7 (14.6) | 0.01§¶ |
Operative approach† | |||
Open | 17 (73.9) | 4 (57.1) | 0.7§¶ |
Laparoscopic | 5 (21.7) | 3 (42.9) | |
Bowel resection | 9 (8.6) | 2 (4.2) | 0.5§¶ |
Timing of radiographic resolution after WSC administration, h‡ | |||
4 | — | 24 (58.5) | 0.04¶** |
24 | — | 12 (29.3) | |
Time to surgery, median, d | 1 | 1 | 0.2§†† |
WSC = water-soluble contrast.
Except where noted otherwise.
Denominator is the number of patients in each cohort who proceeded to surgery (initially or after failed nonoperative trial).
In 12 patients the SBO resolved after 24 hours, at which point no radiograph would have been obtained.
Comparing WSC versus no WSC.
χ2 test.
Comparing resolution at 4 hours versus 24 hours.
Wilcoxon rank-sum test.